|
Market Closed -
NSE India S.E.
19:05:10 15/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 521.20 INR | +0.29% |
|
-4.58% | +17.96% |
| Market Cap | 36.62B 385M 343M 319M 290M 547M 557M 3.83B 1.5B 19.08B 1.45B 1.41B 60.92B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 38.72B 407M 363M 337M 307M 578M 589M 4.05B 1.59B 20.18B 1.53B 1.5B 64.43B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | +0.29% | ||
| 1 week | -4.58% | ||
| Current month | -4.45% | ||
| 1 month | -3.43% | ||
| 3 months | -10.35% | ||
| 6 months | +54.77% | ||
| Current year | +17.96% |
| 1 week | 518 |  | 540.95 |
| 1 month | 497.8 | | 608 |
| Current year | 278.2 | | 687.2 |
| 1 year | 278.2 | | 687.2 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | -4.58% | - | - | 385M | |
| +3.55% | +5.29% | +54.07% | +105.45% | 1,077B | |
| -0.25% | -2.00% | +32.71% | +61.48% | 612B | |
| +0.59% | +4.44% | +23.69% | +91.54% | 501B | |
| -1.48% | +1.68% | +71.42% | +39.59% | 364B | |
| +2.37% | +5.47% | +32.67% | +48.87% | 353B | |
| +2.64% | +4.90% | +21.01% | +43.85% | 278B | |
| +3.24% | +4.25% | -0.31% | +15.71% | 251B | |
| +1.86% | +5.07% | +47.70% | +52.77% | 230B | |
| +2.49% | +7.16% | +32.82% | +102.67% | 190B | |
| Average | +1.58% | +1.97% | +35.09% | +62.44% | 428.5B | |
| Weighted average by Cap. | +1.26% | +1.58% | +39.06% | +71.72% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 222M 198M 184M 167M 315M 321M 2.21B 864M 11B 833M 816M 35.12B | 22.02B 232M 207M 192M 175M 329M 335M 2.3B 902M 11.47B 869M 851M 36.63B |
| Net income | 1.38B 14.47M 12.9M 11.97M 10.9M 20.53M 20.91M 144M 56.32M 716M 54.28M 53.14M 2.29B | 2.53B 26.6M 23.72M 22.01M 20.04M 37.75M 38.44M 265M 104M 1.32B 99.8M 97.69M 4.21B |
| Net Debt | 3.7B 38.95M 34.72M 32.23M 29.34M 55.27M 56.28M 387M 152M 1.93B 146M 143M 6.16B | 2.11B 22.16M 19.76M 18.34M 16.7M 31.46M 32.03M 220M 86.27M 1.1B 83.16M 81.4M 3.5B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | ₹521.20 | +0.29% | 20,421 |
| 14/10/26 | ₹519.70 | -1.26% | 26,429 |
| 13/10/26 | ₹526.35 | -0.67% | 27,657 |
| 12/10/26 | ₹529.90 | -0.23% | 23,650 |
| 09/10/26 | ₹531.10 | +0.04% | 74,517 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
